
Chadi Nabhan, MD, MBA, is a hematologist and medical oncologist specializing in hematologic malignancies, AI, and precision oncology. He serves as Chief Medical Officer and Head of Strategy at Ryght, AI, Inc., a company advancing generative AI for clinical research, and is an Affiliate in the Department of Clinical Pharmacy and Outcomes Sciences at the University of South Carolina. Clinically, Dr. Nabhan focuses on hematologic oncology (lymphomas and leukemias,) genomics, AI in cancer care, and precision oncology. His research interests include hematologic malignancies, AI, genomics and precision oncology, and real-world evidence and outcomes research. A recognized leader and communicator, he has held senior roles across academia and industry, including chairing the Precision Oncology Alliance at Caris Life Sciences and serving in CMO positions at Cardinal Health Specialty Solutions and Aptitude Health; he also serves on the JAMA Oncology editorial board and received a MarCom Gold award for his podcast. He is the creator and host the weekly award-winning Healthcare Unfiltered Podcast. He also has anotehr shorter podcast titled "Healthcare Unfiltered EXPRESS" that tackles recent advances in oncology and covers scientific oncology meetings. Dr. Nabhan earned his medical degree in Damascus, completed internal medicine residency at Loyola University Chicago, and a hematology/medical oncology fellowship at Northwestern University and the Robert H. Lurie Comprehensive Cancer Center. Dr. Nabhan has authored two books: "Toxic Exposure" and "The Cancer Journey" both published by Johns Hopkins University Press - he has two titles coming out in late 2026 including a medical fiction thriller.
Attending Physician - CMO; Ryght AI
Medical School
1991
Residency
Fellowship